{"id":"https://openalex.org/W2795175208","doi":"https://doi.org/10.1200/jco.2013.31.15_suppl.3096","title":"Safety and efficacy of the HER2-derived GP2 peptide vaccine in combination with trastuzumab for breast cancer patients in the adjuvant setting.","display_name":"Safety and efficacy of the HER2-derived GP2 peptide vaccine in combination with trastuzumab for breast cancer patients in the adjuvant setting.","publication_year":2013,"publication_date":"2013-05-20","ids":{"openalex":"https://openalex.org/W2795175208","doi":"https://doi.org/10.1200/jco.2013.31.15_suppl.3096","mag":"2795175208"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2013.31.15_suppl.3096","doi":"https://doi.org/10.1200/jco.2013.31.15_suppl.3096","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2013.31.15_suppl.3096","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113847100","display_name":"Ritesh Patil","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ritesh Patil","raw_affiliation_strings":["Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050537038","display_name":"Guy Travis Clifton","orcid":"https://orcid.org/0000-0001-5962-3876","observed_orcids":["https://orcid.org/0000-0001-5962-3876"]},"institutions":[{"id":"https://openalex.org/I4210140817","display_name":"Blanchfield Army Community Hospital","ror":"https://ror.org/05668ct49","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210140817"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Guy T. Clifton","raw_affiliation_strings":["Blanchfield Army Community Hospital, Fort Campbell, KY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Blanchfield Army Community Hospital, Fort Campbell, KY","institution_ids":["https://openalex.org/I4210140817"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014713051","display_name":"Jennifer Keating Litton","orcid":"https://orcid.org/0000-0001-8390-4985","observed_orcids":["https://orcid.org/0000-0001-8390-4985"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer Keating Litton","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066061720","display_name":"Nathan M. Shumway","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1289568071","display_name":"Brooke Army Medical Center","ror":"https://ror.org/00m1mwc36","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289568071","https://openalex.org/I1330347796","https://openalex.org/I2800250139","https://openalex.org/I2800386880"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nathan M. Shumway","raw_affiliation_strings":["San Antonio Military Medical Center, Fort Sam Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"San Antonio Military Medical Center, Fort Sam Houston, TX","institution_ids":["https://openalex.org/I1289568071"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065391640","display_name":"Timothy J. Vreeland","orcid":"https://orcid.org/0000-0003-4593-7502","observed_orcids":["https://orcid.org/0000-0003-4593-7502"]},"institutions":[{"id":"https://openalex.org/I1289568071","display_name":"Brooke Army Medical Center","ror":"https://ror.org/00m1mwc36","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289568071","https://openalex.org/I1330347796","https://openalex.org/I2800250139","https://openalex.org/I2800386880"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Timothy J Vreeland","raw_affiliation_strings":["Brooke Army Medical Center, San Antonio, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Brooke Army Medical Center, San Antonio, TX","institution_ids":["https://openalex.org/I1289568071"]}]},{"author_position":"middle","author":{"id":null,"display_name":"John S. Berry","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1289568071","display_name":"Brooke Army Medical Center","ror":"https://ror.org/00m1mwc36","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289568071","https://openalex.org/I1330347796","https://openalex.org/I2800250139","https://openalex.org/I2800386880"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John S. Berry","raw_affiliation_strings":["Brooke Army Medical Center, San Antonio, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Brooke Army Medical Center, San Antonio, TX","institution_ids":["https://openalex.org/I1289568071"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108356086","display_name":"Alfred Francois Trappey","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1289568071","display_name":"Brooke Army Medical Center","ror":"https://ror.org/00m1mwc36","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289568071","https://openalex.org/I1330347796","https://openalex.org/I2800250139","https://openalex.org/I2800386880"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alfred F Trappey","raw_affiliation_strings":["Brooke Army Medical Center, San Antonio, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Brooke Army Medical Center, San Antonio, TX","institution_ids":["https://openalex.org/I1289568071"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066190550","display_name":"Sathibalan Ponniah","orcid":"https://orcid.org/0000-0001-8583-4087","observed_orcids":["https://orcid.org/0000-0001-8583-4087"]},"institutions":[{"id":"https://openalex.org/I148314036","display_name":"Uniformed Services University of the Health Sciences","ror":"https://ror.org/04r3kq386","country_code":"US","type":"education","lineage":["https://openalex.org/I148314036"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sathibalan Ponniah","raw_affiliation_strings":["Cancer Vaccine Development Program, United States Military Cancer Institute, USUHS, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Vaccine Development Program, United States Military Cancer Institute, USUHS, Bethesda, MD","institution_ids":["https://openalex.org/I148314036"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044161354","display_name":"George Earl Peoples","orcid":"https://orcid.org/0000-0001-7118-8205","observed_orcids":["https://orcid.org/0000-0001-7118-8205"]},"institutions":[{"id":"https://openalex.org/I1289568071","display_name":"Brooke Army Medical Center","ror":"https://ror.org/00m1mwc36","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289568071","https://openalex.org/I1330347796","https://openalex.org/I2800250139","https://openalex.org/I2800386880"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"George Earl Peoples","raw_affiliation_strings":["Department of Surgery, Brooke Army Medical Center, Fort Sam Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Surgery, Brooke Army Medical Center, Fort Sam Houston, TX","institution_ids":["https://openalex.org/I1289568071"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5029062544","display_name":"Elizabeth Ann Mittendorf","orcid":"https://orcid.org/0000-0002-9762-8536","observed_orcids":["https://orcid.org/0000-0002-9762-8536"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elizabeth Ann Mittendorf","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"31","issue":"15_suppl","first_page":"3096","last_page":"3096"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.6439999938011169,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.6439999938011169,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.3359000086784363,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.004600000102072954,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/trastuzumab","display_name":"trastuzumab","score":0.9869999885559082},{"id":"https://openalex.org/keywords/her2-positive-breast-cancer","display_name":"HER2-positive breast cancer","score":0.8569999933242798},{"id":"https://openalex.org/keywords/adjuvant-therapy","display_name":"adjuvant therapy","score":0.953000009059906},{"id":"https://openalex.org/keywords/cytotoxic-t-lymphocytes","display_name":"cytotoxic T lymphocytes","score":0.8500000238418579},{"id":"https://openalex.org/keywords/vaccine-toxicity","display_name":"vaccine toxicity","score":0.6340000033378601},{"id":"https://openalex.org/keywords/ejection-fraction","display_name":"ejection fraction","score":0.703000009059906},{"id":"https://openalex.org/keywords/injection-site-reactions","display_name":"injection site reactions","score":0.5979999899864197},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.4259999990463257},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.5899999737739563},{"id":"https://openalex.org/keywords/vaccine-safety-and-efficacy","display_name":"vaccine safety and efficacy","score":0.335999995470047}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9096429347991943},{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.7767608761787415},{"id":"https://openalex.org/C2779053233","wikidata":"https://www.wikidata.org/wiki/Q731235","display_name":"ELISPOT","level":4,"score":0.7150343656539917},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6804769039154053},{"id":"https://openalex.org/C2777863537","wikidata":"https://www.wikidata.org/wiki/Q357896","display_name":"Adjuvant","level":2,"score":0.6058682799339294},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5867395401000977},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.49401193857192993},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.46380189061164856},{"id":"https://openalex.org/C2776802502","wikidata":"https://www.wikidata.org/wiki/Q417589","display_name":"Anthracycline","level":4,"score":0.4599202871322632},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.39813560247421265},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.3821718692779541},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3577263653278351},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3458106219768524},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.16788095235824585}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2013.31.15_suppl.3096","doi":"https://doi.org/10.1200/jco.2013.31.15_suppl.3096","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2013.31.15_suppl.3096","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2507448865","https://openalex.org/W2300404593","https://openalex.org/W3170993099","https://openalex.org/W2155257058","https://openalex.org/W2119837274","https://openalex.org/W2051052135","https://openalex.org/W1866903156","https://openalex.org/W4250096504","https://openalex.org/W2620623242","https://openalex.org/W1516179705"],"abstract_inverted_index":{"3096":[0],"Background:":[1],"GP2":[2,12,65,319],"is":[3,325],"a":[4,55,90],"9":[5],"amino":[6],"acid":[7],"HLA-A2/A3":[8,70],"restricted":[9],"HER2-derived":[10],"peptide.":[11],"+":[13,71],"GM-CSF":[14],"has":[15,34],"been":[16],"shown":[17],"to":[18,45,59,253,342],"be":[19],"safe":[20,327],"and":[21,67,150,165,207,211,219,304,328,345],"effective":[22],"in":[23,28,114,142,151,239,283,321,330,335],"eliciting":[24],"anti-HER2":[25],"immune":[26],"response":[27,139],"breast":[29,76,332],"cancer":[30,77,333],"patients.":[31],"Preclinical":[32],"data":[33],"demonstrated":[35,280],"that":[36],"pretreatment":[37],"of":[38,63,103,157,205,287],"cells":[39],"with":[40,73,95,116,323],"trastuzumab":[41],"(Tz)":[42],"enhances":[43],"susceptibility":[44],"lysis":[46],"by":[47,144,153,160,169,293],"GP2-specific":[48,158,291],"cytotoxic":[49],"T":[50],"lymphocytes":[51],"(CTLs).":[52],"We":[53],"conducted":[54],"phase":[56],"Ib":[57],"study":[58,86],"evaluate":[60],"the":[61,64,104,155,284,336],"combination":[62,115,322],"vaccine":[66,105,320],"Tz.":[68],"Methods:":[69],"patients":[72,173,334],"HER2":[74],"overexpressing":[75],"receiving":[78],"Tz":[79,117,324],"as":[80,89,107],"standard":[81],"therapy":[82],"were":[83,185,201,215,224,349],"enrolled.":[84],"The":[85],"was":[87,120,133,140,235,260,340],"designed":[88],"3+3":[91],"dose":[92,101,351],"escalation":[93],"trial":[94],"an":[96,281],"expansion":[97],"cohort":[98],"evaluating":[99],"4":[100,229],"levels":[102],"administered":[106],"6":[108,248],"inoculations":[109],"given":[110],"every":[111,135],"3":[112,136,227,242],"weeks":[113],"(6mg/kg).":[118],"Toxicity":[119,128,339],"graded":[121],"48-72":[122],"hr":[123],"post":[124],"vaccination":[125,265],"using":[126],"NCI":[127],"Criteria.":[129],"Ejection":[130],"fraction":[131],"(EF)":[132],"monitored":[134],"mo.":[137],"Immunologic":[138],"assessed":[141],"vivo":[143],"injection":[145],"site":[146],"local":[147,199,230,344],"reaction":[148],"(LR)":[149],"vitro":[152,278],"quantifying":[154],"number":[156,286],"CTLs":[159,292],"HLA-A2:":[161],"IgG":[162],"dimer":[163,294],"assays":[164,279],"their":[166],"functional":[167],"activity":[168,307],"ELISPOT.":[170],"Results:":[171],"19":[172],"enrolled":[174],"(median":[175],"age":[176],"47":[177],"yr,":[178],"mean":[179],"tumor":[180],"size":[181],"3.4":[182],"cm,":[183],"74%":[184,193],"grade":[186,202,208,216,220,226],"3,":[187],"53%":[188],"ER/PR+,":[189],"63%":[190],"node":[191],"positive,":[192],"received":[194],"anthracycline":[195],"based":[196],"therapy).":[197],"Maximum":[198],"toxicities":[200,214,353],"1":[203,217],"(77%":[204],"patients)":[206],"2":[209,221],"(6%),":[210],"maximum":[212],"systemic":[213,232,346],"(24%)":[218],"(5%).":[222],"There":[223,234,348],"no":[225,236,350],"or":[228,231,247,354],"toxicities.":[233],"significant":[237],"change":[238],"EF":[240],"at":[241],"mo":[243,249],"(57\u00b1":[244],"1%,":[245],"p=0.23)":[246],"(59\u00b11%,":[250],"p=0.8)":[251],"compared":[252],"baseline":[254],"(58\u00b10.9%).":[255],"Mean":[256],"post-vaccine":[257],"series":[258],"LR":[259,266],"significantly":[261],"larger":[262],"than":[263],"initial":[264],"(68.2":[267],"\u00b1":[268,273,297,301],"8.6":[269],"mm":[270],"vs":[271,299,312],"28.0":[272],"10.3":[274],"mm,":[275],"p=0.0004).":[276],"In":[277],"increase":[282],"maximal":[285],"post-":[288],"versus":[289],"pre-vaccination":[290],"assay":[295],"(1.45":[296],"0.19":[298],"0.96":[300],"0.19%,":[302],"p=0.06)":[303],"increased":[305],"ELISPOT":[306],"[median":[308],"86":[309],"range":[310],"(3-194)":[311],"34":[313],"(range":[314],"0-295)":[315],"spots/106":[316],"cells].":[317],"Conclusions:":[318],"both":[326],"immunogenic":[329],"HER2-overexpressing":[331],"adjuvant":[337],"setting.":[338],"limited":[341],"mild":[343],"reactions.":[347],"limiting":[352],"cardiac":[355],"events.":[356]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2014,"cited_by_count":2}],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2018-04-06T00:00:00"}